FDA unease about faster drug approval

    loading  Checking for direct PDF access through Ovid

Abstract

A little noticed FDA report reveals internal opposition to Trump plans to speed drugs to market. Peter Doshi looks at its arguments

Related Topics

    loading  Loading Related Articles